Arcade Therapeutics Named to the New York Digital Health 100

New York, NY (February 6, 2024) – Arcade Therapeutics today announced that it has been named to the 2024 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York. Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report which takes an in-depth look at the investment trends, opportunities and challenges in the digital health sector. 

“As a long time New York area founder, I truly appreciate this honor recognizing our work to impact mental health treatment at Arcade Therapeutics,” said Raj Amin, Co-Founder and CEO of Arcade Therapeutics. “We are grateful to DHNY for bringing focus to the NYC health community and the level of innovation happening here.”

“2024 marks the fifth year of the New York Digital Health 100 and in that time, the digital health ecosystem in New York has significantly grown and evolved,” said Bunny Ellerin, Co-Founder and CEO, DHNY. “We are proud to recognize these exceptional organizations and commend them for their ongoing commitment to innovation, transformation and the role they play in driving healthcare forward.” 

To download a copy of the New York Healthcare Innovation Report, please click here.

About Arcade Therapeutics
Arcade Therapeutics is a science-first game studio dedicated to treating mental illness by combining the most cutting edge cognitive neuroscience with engaging games. Arcade’s mission is to radically transform the mental health journey through highly accessible, clinically validated therapeutic games. Its NYC-based team includes leaders in clinical research, consumer products, game development, and healthcare strategy. To learn more visit https://arcadetherapeutics.com/. 

About Digital Health New York (DHNY)
Digital Health New York (DHNY) is a connected community of digital health leaders who share ideas, spark new directions and create success across the entire ecosystem. As an organization, we seek to increase the visibility of New York City as a leader in healthcare innovation and showcase the companies and leaders creating the future of healthcare. Our flagship event, DHNY Summit, brings together an elite group of entrepreneurs, investors, payers, providers and executives to cultivate the New York digital health community and drive impactful conversations around the current and future state of digital health. DHNY was founded in 2022 in collaboration with AlleyCorp. For more information or to join DHNY’s mailing list, please visit www.dhny.co.

DH100 Methodology
To compile the DH100, we invited companies to complete an in-depth application with both quantitative and qualitative measures to help us to get to know the company better. We also used our dynamic database of digital health companies in the region to round out the consideration set. A company qualified for consideration if it maintained headquarters or employed at least 10 people in the New York region. Companies that were public or non-profit; founded before 2014; or had an exit were excluded. We evaluated companies on a number of factors, including but not limited to: strength of application, leadership, number of employees, funding (if known), revenue (if known), market fit, differentiated offerings, and community engagement.

***END***

Contact: Nayan Ghosh, nayan@arcadetherapeutics.com